Hmdb loader
Record Information
Version5.0
StatusPredicted
Creation Date2021-09-13 20:58:10 UTC
Update Date2022-11-30 20:03:56 UTC
HMDB IDHMDB0283172
Secondary Accession NumbersNone
Metabolite Identification
Common NamePS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9))
DescriptionPS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396 ). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one 13Z,16Z-docosadienoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396 ). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396 ). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396 ).
Structure
Thumb
Synonyms
ValueSource
(2S)-2-Amino-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)propanoateGenerator
Chemical FormulaC46H80NO11P
Average Molecular Weight854.116
Monoisotopic Molecular Weight853.546899398
IUPAC Name(2S)-2-amino-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)propanoic acid
Traditional Name(2S)-2-amino-3-{[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy}propoxy(hydroxy)phosphoryl]oxy}propanoic acid
CAS Registry NumberNot Available
SMILES
[H][C@@](COC(=O)CCCCCCCCCCC\C=C/C\C=C/CCCCC)(COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCC(O)\C=C\C=C\C\C=C\CC
InChI Identifier
InChI=1S/C46H80NO11P/c1-3-5-7-9-11-12-13-14-15-16-17-18-19-20-21-22-24-28-32-36-44(49)55-38-42(39-56-59(53,54)57-40-43(47)46(51)52)58-45(50)37-33-29-25-27-31-35-41(48)34-30-26-23-10-8-6-4-2/h6,8,11-12,14-15,23,26,30,34,41-43,48H,3-5,7,9-10,13,16-22,24-25,27-29,31-33,35-40,47H2,1-2H3,(H,51,52)(H,53,54)/b8-6+,12-11-,15-14-,26-23+,34-30+/t41?,42-,43+/m1/s1
InChI KeyJOFFJHZBZCEYKO-GADWGZGKSA-N
Chemical Taxonomy
ClassificationNot classified
Ontology
Physiological effectNot Available
Disposition
Process
Role
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.7ALOGPS
logP10.01ChemAxon
logS-7.1ALOGPS
pKa (Strongest Acidic)1.47ChemAxon
pKa (Strongest Basic)9.38ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area191.91 ŲChemAxon
Rotatable Bond Count43ChemAxon
Refractivity240.74 m³·mol⁻¹ChemAxon
Polarizability101.13 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+298.04232859911
AllCCS[M+H-H2O]+298.0732859911
AllCCS[M+Na]+297.96132859911
AllCCS[M+NH4]+297.98332859911
AllCCS[M-H]-296.50832859911
AllCCS[M+Na-2H]-303.62132859911
AllCCS[M+HCOO]-311.4132859911
DeepCCS[M+H]+299.6430932474
DeepCCS[M-H]-297.74530932474
DeepCCS[M-2H]-330.98630932474
DeepCCS[M+Na]+305.95830932474

Predicted Kovats Retention Indices

Not Available
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 10V, Positive-QTOFsplash10-0udi-0000001090-81cc059d00f51e1497d22021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 20V, Positive-QTOFsplash10-0gb9-0003069160-d914dc4b05b102a5f4de2021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 40V, Positive-QTOFsplash10-014i-0003069110-e8c2c14f8138263d166e2021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 10V, Positive-QTOFsplash10-04vi-0000009990-284f7885528efc6339042021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 20V, Positive-QTOFsplash10-04vo-0900009990-1b4564cc442d4bef8de32021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 40V, Positive-QTOFsplash10-04vo-0900009990-1b4564cc442d4bef8de32021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 10V, Positive-QTOFsplash10-004r-0000001690-ae9860d43c1c5d1c37582021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 20V, Positive-QTOFsplash10-004i-0000000290-749dda38dae5d12178902021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 40V, Positive-QTOFsplash10-0a4i-0090003310-6f8b521718a2209c73ae2021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 10V, Negative-QTOFsplash10-0udi-0000000090-bba9da5e5e5d5744759f2021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 20V, Negative-QTOFsplash10-0udi-0000000190-2379d0c2681904b07e842021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PS(22:2(13Z,16Z)/18:3(10,12,15)-OH(9)) 40V, Negative-QTOFsplash10-0gkl-0033900530-50948fb343f8c0e2f3512021-10-19Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Hajeyah AA, Griffiths WJ, Wang Y, Finch AJ, O'Donnell VB: The Biosynthesis of Enzymatically Oxidized Lipids. Front Endocrinol (Lausanne). 2020 Nov 19;11:591819. doi: 10.3389/fendo.2020.591819. eCollection 2020. [PubMed:33329396 ]